This study excludes discussion or sales analysis of therapeutic antibiotics and agricultural pesticides, even though a large percentage of them act as either inhibitors or blockers. An Appendix briefly mentions a few of the antibiotics. Readers should note that this study emphasizes the commercial aspects of enzyme inhibitors and receptor blockers and their practical medical applications. Although this study discusses some of the relevant basic research, this study does not constitute a roundup or comprehensive review of basic scientific research merely happening to take place in company settings. Secondary sources of information encompass available company literature, scientific journals, medical literature and the trade press.
All figures refer to worldwide sales unless indicated otherwise.
Forecasts are made to the year 2000 and are expressed in constant 1995 dollars to reflect real changes without inflation. All analyses are made independently, without the bias of vested interests. Mentions of products and companies are not endorsements, and omissions, if any, are not intentional. The analyst of this study is a chemist and biochemist who also has an M.B.A. degree. Having both academic and industrial laboratory research experience at senior levels, he has been writing technical-business studies at BCC for 13 years and serves as its biotechnology director.